Reuters logo
BRIEF-Insys Therapeutics Drug Enforcement Agency issued an interim final rule
2017年3月23日 / 中午11点44分 / 8 个月前

BRIEF-Insys Therapeutics Drug Enforcement Agency issued an interim final rule

March 23 (Reuters) - Insys Therapeutics Inc:

* Insys Therapeutics-drug enforcement agency issued interim final rule that would result in syndros being placed in schedule II of Controlled Substances Act

* Insys Therapeutics Inc - “look forward to interacting with FDA to finalize labeling and subsequent launch of Syndros in second half of 2017” Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below